KonéPefoyo AJ, Bronskill SE, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, et al. The increasing burden and complexity of multimorbidity disease epidemiology – Chronic. BMC Public Health. 2015;15(1):1–11.
Head A, Fleming K, Kypridemos C, Schofield P, Pearson-Stuttard J, O’Flaherty M. Inequalities in incident and prevalent multimorbidity in England, 2004–19: a population-based, descriptive study. Lancet Healthy Longev. 2021;2(8):e489–97.
Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–51.
Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS ONE. 2014;9(7):3–11.
Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health. 2018;42(2):186–94.
Mondor L, Cohen D, Khan AI, Wodchis WP. Income inequalities in multimorbidity prevalence in Ontario, Canada: a decomposition analysis of linked survey and health administrative data. Int J Equity Health. 2018;17(1):1–13.
KonéPefoyo A, Mondor L, Maxwell C, Kabir US, Rosella LC, Wodchis WP. Rising burden of multimorbidity and related socio-demographic factors: a repeated cross-sectional study of Ontarians. Can J Public Health. 2021;112(4):737–47.
Cassell A, Edwards D, Harshfield A, Rhodes K, Brimicombe J, Payne R, et al. The epidemiology of multimorbidity in primary care: A retrospective cohort study. Br J Gen Pract. 2018;68(669):e245–51.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380(9836):37–43.
Stafford M, Steventon A, Thorlby R, Fisher R, Turton C, Deeny S. Briefing: Understanding the health care needs of people with multiple health conditions. London (UK): The Health Foundation; 2018. Available from: https://www.health.org.uk/publications/understanding-the-health-care-needs-of-people-with-multiple-health-conditions. [Cited 2022 Apr 20].
Moin JS, Moineddin R, Upshur REG. Measuring the association between marginalization and multimorbidity in Ontario, Canada: A cross-sectional study. J Comorb. 2018;8(1):2235042X1881493.
Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2018;64:30–9.
Jani BD, Hanlon P, Nicholl BI, McQueenie R, Gallacher KI, Lee D, et al. Relationship between multimorbidity, demographic factors and mortality: Findings from the UK Biobank cohort. BMC Med. 2019;17(1):1–13.
Nunes BP, Flores TR, Mielke GI, Thumé E, Facchini LA. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2016;67:130–8.
Hanlon P, Jani BD, Nicholl B, Lewsey J, McAllister DA, Mair FS. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: a comparison of longitudinal cohort studies. PLoS Med. 2022;19(3):e1003931.
Munyombwe T, Dondo TB, Aktaa S, Wilkinson C, Hall M, Hurdus B, et al. Association of multimorbidity and changes in health-related quality of life following myocardial infarction: a UK multicentre longitudinal patient-reported outcomes study. BMC Med. 2021;19(1):227.
Hajat C, Stein E. The global burden of multiple chronic conditions: a narrative review. Prev Med Rep. 2018;12(September):284–93. https://doi.org/10.1016/j.pmedr.2018.10.008.
Tran PB, Kazibwe J, Nikolaidis GF, Linnosmaa I, Rijken M, van Olmen J. Costs of multimorbidity: a systematic review and meta-analyses. BMC Med. 2022;20(1):1–15. https://doi.org/10.1186/s12916-022-02427-9.
Mbuya-Bienge C, Simard M, Gaulin M, Candas B, Sirois C. Does socio-economic status influence the effect of multimorbidity on the frequent use of ambulatory care services in a universal healthcare system? A population-based cohort study. BMC Health Serv Res. 2021;21(1):1–11.
Gopfert A, Deeny SR, Fisher R, Stafford M. Primary care consultation length by deprivation and multimorbidity in England: an observational study using electronic patient records. Br J Gen Pract. 2021;71(704):E185–92.
Palladino R, Lee JT, Ashworth M, Triassi M, Millett C. Associations between multimorbidity, healthcare utilisation and health status: Evidence from 16 European countries. Age Ageing. 2016;45(3):431–5.
Dean T, Koné A, Martin L, Armstrong J, Sirois C. Understanding the Extent of Polypharmacy and its Association With Health Service Utilization Among Persons With Cancer and Multimorbidity: A Population-Based Retrospective Cohort Study in Ontario. Canada J Pharm Pract. 2022;0(0):1–12.
Stairmand J, Signal L, Sarfati D, Jackson C, Batten L, Holdaway M, et al. Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review. Ann Oncol. 2015;26(7):1325–32. https://doi.org/10.1093/annonc/mdv025.
Chen RC, Royce TJ, Extermann M, Reeve BB. Impact of age and comorbidity on treatment and outcomes in elderly cancer patients. Semin Radiat Oncol. 2012;22(4):265–71.
Koné AP, Scharf D. Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study. BMC Cancer. 2021;21(1):1–13.
Maxwell CJ, Mondor L, PefoyoKoné AJ, Hogan DB, Wodchis WP. Sex differences in multimorbidity and polypharmacy trends: a repeated cross-sectional study of older adults in Ontario, Canada. PLoS One. 2021;16(4 April):1–17.
Jensen NL, Pedersen HS, Vestergaard M, Mercer SW, Glümer C, Prior A. The impact of socioeconomic status and multimorbidity on mortality: a population-based cohort study. Clin Epidemiol. 2017;9:279–89.
Dugravot A, Fayosse A, Dumurgier J, Bouillon K, Rayana TB, Schnitzler A, et al. Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study. Lancet Public Health. 2020;5(1):e42-50.
Diderichsen F, Bender AM, Lyth AC, Andersen I, Pedersen J, Bjørner JB. Mediating role of multimorbidity in inequality in mortality: a register study on the Danish population. J Epidemiol Community Health (1978). 2021. https://doi.org/10.1136/jech-2021-218211.
Chan MS, van den Hout A, Pujades-Rodriguez M, Jones MM, Matthews FE, Jagger C, et al. Socio-economic inequalities in life expectancy of older adults with and without multimorbidity: a record linkage study of 1.1 million people in England. Int J Epidemiol. 2019;48(4):1340–51.
Lane NE, Maxwell CJ, Gruneir A, Bronskill SE, Wodchis WP. Absence of a Socioeconomic Gradient in Older Adults’ Survival with Multiple Chronic Conditions. EBioMedicine. 2015;2(12):2094–100.
Charlton J, Rudisill C, Bhattarai N, Gulliford M. Impact of deprivation on occurrence, outcomes and health care costs of people with multiple morbidity. J Health Serv Res Policy. 2013;18(4):215–23.
Marmot M, Allen J, Boyce T, Goldblatt P, Morrison J. Health Equity in England: The Marmot Review 10 Years on. London (UK): The Health Foundation. Available from: https://www.health.org.uk/publications/reports/the-marmot-review-10-years-on. [February 2020; cited 2022 Apr 20].
Shahidi FV, Parnia A, Siddiqi A. Trends in socioeconomic inequalities in premature and avoidable mortality in Canada, 1991–2016. CMAJ. 2020;192(39):E1114–28.
Office of National Statistics. Trend in life expectancy at birth and at age 65 by socio-economic position based on the National Statistics Socio-economic Classification, England and Wales: 1982—1986 to 2007—2011. Office of National Statistics; 2015. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/bulletins/trendinlifeexpectancyatbirthandatage65bysocioeconomicpositionbasedonthenationalstatisticssocioeconomicclassificationenglandandwales/2015-10-21. [Cited 2022 Apr 20].
Office of National Statistics. Socioeconomic inequalities in avoidable mortality in England: 2019 [Internet]. Office of National statistics; 2021. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/socioeconomicinequalitiesinavoidablemortalityinengland/2019. [Cited 2022 Apr 20].
Kraftman L, Hardelid P, Banks J. Age specific trends in mortality disparities by socio-economic deprivation in small geographical areas of England, 2002–2018: a retrospective registry study. The Lancet Regional Health – Europe. 2021;7:100136.
Banks J, Cattan S, Kraftman L, Krutikova S. Mortality Inequality in England over the Past 20 Years. Fisc Stud. 2021;42(1):47–77.
Cookson R, Mondor L, Asaria M, Kringos DS, Klazinga NS, Wodchis WP. Primary care and health inequality: difference-in-difference study comparing England and Ontario. PLoS One. 2017;12(11):e0188560.
Anderson G, Frank JW, Naylor CD, Wodchis W, Feng P. Using socioeconomics to counter health disparities arising from the covid-19 pandemic. BMJ. 2020:369:m2149.
Wolf A, Dedman D, Campbell J, Booth H, Lunn D, Chapman J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol. 2019;48(6):1740-1740G.
National data opt-out. NHS Digital; 2022. Available from: https://digital.nhs.uk/services/national-data-opt-out#:~:text=The%20national%20data%20opt%2Dout,used%20for%20research%20and%20planning.&text=Patients%20can%20find%20out%20more,choice%20on%20the%20NHS%20website. [Cited 2022 Oct 27].
Ministry of Housing Communities & Local Government. The English Indices of Deprivation 2015. Department for Communities and Local Government; 2015. Available from: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015. [Cited 2022 Apr 20].
Matheson FI, Moloney G van IT. 2016 Ontario marginalization index: user guide. Public Health Ontario, Centre for Urban Health Solutions & St Michael’s Unity Health Toronto; 2022. Available from: https://www.publichealthontario.ca/-/media/documents/o/2017/on-marg-userguide.pdf. [Cited 2022 Apr 20].
Kuan V, Denaxas S, Gonzalez-Izquierdo A, Direk K, Bhatti O, Husain S, et al. A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service. Lancet Digit Health. 2019;1(2):e63-77.
Lix LM, Ayles J, Bartholomew S, Cooke CA, Ellison J, Emond V, et al. The Canadian Chronic Disease Surveillance System: A model for collaborative surveillance. Int J Popul Data Sci. 2018;3(3):433.
Canadian Chronic Disease Surveillance System (CCDSS) [Internet]. Canada: Government of Canada; 2021. Available from: https://health-infobase.canada.ca/ccdss/data-tool/. [Cited 2022 Apr 20].
Lapointe-Shaw L, Bouck Z, Howell NA, Lange T, Orchanian-Cheff A, Austin PC, et al. Mediation analysis with a time-to-event outcome: a review of use and reporting in healthcare research. BMC Med Res Methodol. 2018;18(1):1–12.
Paddison CAM, Saunders CL, Abel GA, Payne RA, Campbell JL, Roland M. Why do patients with multimorbidity in England report worse experiences in primary care? Evidence from the general practice patient survey. BMJ Open. 2015;5(3):1–10.
Rolewicz L, Keeble E, Paddison C, Scobie S. Are the needs of people with multiple long-term conditions being met? Evidence from the 2018 General Practice Patient Survey. BMJ Open. 2020;10(11):e041569.
Ronksley PE, Sanmartin C, Quan H, Ravani P, Tonelli M, Manns B, et al. Association between chronic conditions and perceived unmet health care needs. Open Medicine. 2012;6(2):48–58.
Ham C, Dixon A. Brooke B. Transforming the delivery of health and social care: the case for fundamental change. London (UK): The Kings Fund; 2012. Available from: https://www.kingsfund.org.uk/publications/transforming-delivery-health-and-social-care. [Cited 2023 Feb 21].
Pedersen SE, Aaby A, Friis K, Maindal HT. Multimorbidity and health literacy: a population-based survey among 28,627 Danish adults. Scand J Public Health. 2021;12:14034948211045920.
Mansour MHH, Pokhrel S, Anokye N. Effectiveness of integrated care interventions for patients with long-term conditions: a review of systematic reviews. Integr Healthcare J. 2022;4(1):e000083.
Bisquera A, Turner EB, Ledwaba-Chapman L, Dunbar-Rees R, Hafezparast N, Gulliford M, et al. Inequalities in developing multimorbidity over time: a population-based cohort study from an urban, multi-ethnic borough in the United Kingdom. Lancet Regional Health – Europe. 2022;12:100247.
McLean G, Gunn J, Wyke S, Guthrie B, Watt GCM, Blane DN, et al. The influence of socioeconomic deprivation on multimorbidity at different ages: a cross-sectional study. Br J Gen Pract. 2014;64(624):440–7.
Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;3(7):e323–32.
O’Brien R, Wyke S, Watt GGCM, Guthrie B, Mercer SW. The ‘Everyday Work’ of Living with Multimorbidity in Socioeconomically Deprived Areas of Scotland. J Comorb. 2014;4(1):1–10.
Coventry PA, Small N, Panagioti M, Adeyemi I, Bee P. Living with complexity; Marshalling resources: a systematic review and qualitative meta-synthesis of lived experience of mental and physical multimorbidity Multimorbidity in Primary Care Knowledge, attitudes, behaviors, education, and communication. BMC Fam Pract. 2015;16(1):1–12.
Revealing Reality. You only had to ask. London (UK): The Taskforce on Multiple Conditions (Richmond group of charities, Royal College of General Practitioners and Impact of Urban Health); 2021. Available from: https://richmondgroupofcharities.org.uk/taskforce-multiple-conditions. [Cited 2023 Feb 21].
McCallum M, MacDonald S. Exploring GP work in areas of high socioeconomic deprivation: a secondary analysis. BJGP Open. 2021;5(6):1–12.
Fisher R, Dunn P, Asaria M, Thorlby R. Briefing: Level or not? Comparing general practice in areas of high and low socioeconomic deprivation in England. [Internet]. London (UK): The Health Foundation; 2020. [cited 2023 Feb 21]. Available from: https://www.health.org.uk/publications/reports/level-or-not.
Caughey GE, Ramsay EN, Vitry AI, Gilbert AL, Luszcz MA, Ryan P, et al. Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. J Epidemiol Community Health (1978). 2010;64(12):1036.
Ricci-Cabello I, Violán C, Foguet-Boreu Q, Mounce LTA, Valderas JM. Impact of multi-morbidity on quality of healthcare and its implications for health policy, research and clinical practice. A scoping review. Eur J Gen Pract. 2015;21(3):192–202.
Roy S, Vallepu S, Barrios C, Hunter K. Comparison of Comorbid Conditions Between Cancer Survivors and Age-Matched Patients Without Cancer. J Clin Med Res. 2018;10(12):911–9.
Warner DF, Schiltz NK, Stange KC, Given CW, Owusu C, Berger NA, et al. Complex multimorbidity and health outcomes in older adult cancer survivors. Fam Med Community Health. 2017;5(2):129–38.
Zullig LL, Sung AD, Khouri MG, Jazowski S, Shah NP, Sitlinger A, et al. Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol Elsevier Inc. 2022;4:149–65.
Foster M, Niedzwiedz CL. Associations between multimorbidity and depression among breast cancer survivors within the UK Biobank cohort: a cross-sectional study. BMC Cancer. 2021;21(1):650. https://doi.org/10.1186/s12885-021-08409-z.
Department of Health and Social care. Long Term Conditions Compendium of Information: Third Edition. Department of Health and Social Care; 2012. Available from: https://www.gov.uk/government/publications/long-term-conditions-compendium-of-information-third-edition. [Cited 2022 Apr 20].
Zulman DM, Asch SM, Martins SB, Kerr EA, Hoffman BB, Goldstein MK. Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness. J Gen Intern Med. 2014;29(3):529–37.
Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, et al. Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System. JAMA Netw Open. 2018;1(7):e184852.
Forslund T, Carlsson AC, Ljunggren G, Ärnlöv J, Wachtler C. Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study. Fam Pract. 2021;38(2):132–40.
Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers. 2022;8(1):48.
Stirland LE, González-Saavedra L, Mullin DS, Ritchie CW, Muniz-Terrera G, Russ TC. Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice. BMJ. 2020;18(368):m160.
Ho ISS, Azcoaga-Lorenzo A, Akbari A, Black C, Davies J, Hodgins P, et al. Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies. Lancet Public Health. 2021;6(8):e587-97. https://doi.org/10.1016/S2468-2667(21)00107-9.
Ho ISS, Azcoaga-Lorenzo A, Akbari A, Davies J, Khunti K, Kadam UT, et al. Measuring multimorbidity in research: Delphi consensus study. BMJ Med. 2022;1(1):e000247.
Cooper R, Witham MD, Bartle V, Sayer AA. Defining and measuring multiple long term conditions in research. BMJ Med. 2022;1(1):e000287.
Bhattarai N, Charlton J, Rudisill C, Gulliford MC. Coding, recording and incidence of different forms of coronary heart disease in primary care. PLoS One. 2012;7(1):e29776.
Gulliford MC, Charlton J, Ashworth M, Rudd AG, Toschke AM, Delaney B, et al. Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database. PLoS One. 2009;4(9):e7168.
Public Health England. COVID-19: review of disparities in risks and outcomes. 2020 [updated date 2020 August 11- cited 2022 Apr 20]. Available from: https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes.
Watt T, Firth Z, Fisher R, Thorlby R Kelly E. Use of primary care during the COVID-19 pandemic. London (UK): The Health Foundation; 2020. Available from: https://www.health.org.uk/news-and-comment/charts-and-infographics/use-of-primary-care-during-the-covid-19-pandemic. [Cited 2022 Apr 20].
link